GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS’s Fiscal Year 2026
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to...
Black Book Recaps 2025 Research Announcements and Client‑Rated Honors; Reaffirms Vendor‑Agnostic, Independently Validated Intelligence and 2026 Commitments